Examining the True Prevalence of Hypercortisolism and Its Impact on Managing Resistant Diabetes - Episode 7
Spectrum of Hypercortisolism Presentations
Key opinion leaders explore the diverse clinical manifestations of hypercortisolism across its spectrum of presentations.
Video content above is prompted by the following:
- Can you discuss the spectrum of hypercortisolism and its various clinical presentations, especially in T2D?
- Based on the prevalence data from the CATALYST study, how should we approach screening of patients for hypercortisolism?
- Are there specific subgroups of patients with T2D who may have a higher prevalence of hypercortisolism?
- Can you talk about testing for hypercortisolism? What tests are recommended for screening and subsequent confirmation?
- Can you explain the dexamethasone suppression test (DST) used in the CATALYST study?
